兰卫医学 (301060.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(兰卫医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 436,441,198.761,674,368,547.181,269,876,218.40837,910,261.21412,587,989.384,199,305,065.953,108,826,470.972,060,657,195.36827,689,742.45
 营业利润(元) 2,720,970.17-135,823,689.955,672,007.67-6,129,934.0322,542,611.60949,275,849.96892,731,358.13634,085,434.91279,726,066.78
 利润总额(元) 2,318,722.01-153,243,304.74513,852.66-11,129,636.1019,627,654.96904,443,401.90880,082,843.61628,335,871.61276,654,777.68
 净利润(元) -264,826.54-161,709,404.90-9,367,185.70-17,796,413.8515,591,014.71739,055,163.33732,923,590.45526,709,457.55231,157,344.48
 归属于母公司股东的净利润(元) 1,071,720.66-141,591,451.29-880,075.42-1,822,631.0421,413,081.32617,322,755.95604,318,752.27430,548,324.68177,239,159.96
盈利能力:
 销售毛利率(%) 21.9120.8024.4925.7129.0842.6443.7646.7747.96
 销售净利率(%) -0.06-9.66-0.74-2.123.7817.6023.5825.5627.93
 净资产收益率(%) 0.06-7.37-0.04-0.101.12----
 总资产报酬率ROA(%) 0.05-4.450.08-0.300.69----
 投入资本回报率ROIC(%) 0.05-6.32-0.04-0.080.9131.4431.5623.9910.58
营运能力:
 存货周转率(次) 1.013.453.252.401.09----
 应收账款周转率(次) 0.291.040.690.450.26----
 总资产周转率(次) 0.140.500.380.270.14----
偿债能力:
 资产负债率(%) 31.6833.7030.5033.8133.8639.3436.3434.0524.30
 股东权益比率(%) 61.3659.6062.6959.9760.2155.0757.8860.5770.46
 已获利息倍数(倍) -2.91-43.471.25-6.0226.29119.39169.29411.731,000.29
 流动比率 3.032.833.202.742.772.402.472.663.82
 速动比率 2.512.322.672.352.412.072.182.403.30
发展能力:
 营业收入增长率(%) 5.78-60.13-59.15-59.34-50.15136.14143.91167.17132.24
 营业利润增长率(%) -87.93-114.31-99.36-100.97-91.94197.63229.64326.66260.16
 税后利润增长率(%) -95.00-122.94-100.15-100.42-87.92202.85240.73338.53232.41
 净资产增长率(%) -14.79-13.71-5.962.7619.6631.8433.5342.3432.32
 总资产增长率(%) -16.40-20.28-13.163.7940.0377.9678.9082.9853.59

前瞻产业研究院